Prescient Therapeutics Limited (($AU:PTX)) announced an update on their ongoing clinical study. Prescient Therapeutics Limited is conducting an ...
TipRanks on MSN
Palvella Therapeutics’ Phase 2 Study on PTX-022: A Potential Game-Changer for Cutaneous Venous Malformations
Palvella Therapeutics, Inc. (($PVLA)) announced an update on their ongoing clinical study. Palvella Therapeutics, Inc. is conducting a Phase 2 ...
Brian Sorbe joins AGCO as President of PTx, bringing precision ag leadership to accelerate the company’s offerings of smart farming solutions for almost any brand. AGCO appoints Brian Sorbe as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback